SB-659032 Platelet Aggregation Study

NCT01745458 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: SB-659032
DRUG: Placebo

Sponsor

GlaxoSmithKline